Indolo[3,2-c] coumarin compounds, derivatives thereof and synthesis method thereof
A technology of coumarins and synthetic methods, applied in the direction of steroids, organic chemistry methods, organic chemistry, etc., can solve the problems of low reaction efficiency of toxic and dangerous reagents, high temperature required for reaction conditions, etc., and achieve a wide range of substrates , simple reaction operation and high atom economy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0057] Synthesis of Compound 2a:
[0058]
[0059] Under a nitrogen atmosphere, bis(acetonitrile)palladium dichloride (2.6mg, 0.01mmol), silver trifluoromethanesulfonate (5.1mg, 0.02mmol), dppm (3.8mg, 0.01mmol), acetonitrile (0.5 mL), stirred at room temperature for 10 minutes. Then add alkyne substrate 1a (32.9mg, 0.1mmol), p-benzoquinone (16.2mg, 0.15mmol), acetonitrile (0.5mL), then use CO balloon to pump three times, the reaction system was stirred at room temperature for 3 hours, and the reaction After completion, the solvent was spin-dried, and the compound 2a was separated by column chromatography with a yield of 71% (25.2 mg) as a white solid. 1 H NMR (400MHz, CDCl 3 )δ8.38(m,1H),7.82(d,J=8.0Hz,1H),7.53–7.33(m,5H),7.20(m,1H),7.05(d,J=8.5Hz,2H), 6.85(d, J=8.6Hz, 2H), 5.80(s, 2H), 3.75(s, 3H). 13 C NMR (100MHz, CDCl 3 )δ159.4, 158.7, 153.5, 141.0, 139.7, 130.1, 127.2, 126.9, 125.3, 124.4, 124.1, 123.3, 122.6, 121.8, 118.4, 114.8, 113.6, 109.8, 102.8, 55.3, 2KBr ...
Embodiment 2
[0061] Synthesis of compound 2b:
[0062]
[0063]Under a nitrogen atmosphere, bis(acetonitrile)palladium dichloride (2.6mg, 0.01mmol), silver trifluoromethanesulfonate (5.1mg, 0.02mmol), dppm (3.8mg, 0.01mmol), acetonitrile (0.5 mL), stirred at room temperature for 10 minutes. Then add alkyne substrate 1b (37.8mg, 0.1mmol), p-benzoquinone (16.2mg, 0.15mmol), acetonitrile (0.5mL), and then use CO balloon to pump three times, and the reaction system was stirred at room temperature for 3 hours. After the completion, the solvent was spin-dried, and the compound 2b was separated by column chromatography with a yield of 70% (28.3 mg) as a white solid. 1 H NMR (400MHz, CDCl 3 )δ8.38(dd, J=6.6,1.7Hz,1H),7.92(d,J=2.1Hz,1H),7.57–7.28(m,8H),7.13(d,J=7.0Hz,2H), 5.82(s,2H). 13 C NMR (100MHz, CDCl 3 )δ158.0, 152.2, 140.0, 139.4, 135.1, 132.8, 129.5, 128.4, 125.9, 125.7, 125.3, 124.1, 123.6, 121.9, 119.8, 116.7, 115.1, 109.8, 105.0, 70.0, 72, 42 (KBr)1 ,1428,971,778,754,732. HRMS (...
Embodiment 3
[0065] Synthesis of compound 2c:
[0066]
[0067] Under a nitrogen atmosphere, bis(acetonitrile)palladium dichloride (2.6mg, 0.01mmol), silver trifluoromethanesulfonate (5.1mg, 0.02mmol), dppm (3.8mg, 0.01mmol), acetonitrile (0.5 mL), stirred at room temperature for 10 minutes. Then add alkyne substrate 1c (32.9mg, 0.1mmol), p-benzoquinone (16.2mg, 0.15mmol), acetonitrile (0.5mL), and then use CO balloon to pump three times, and the reaction system was stirred at room temperature for 3 hours. After completion, the solvent was spin-dried, and compound 2c was separated by column chromatography with a yield of 61% (21.7 mg) as a white solid. 1 H NMR (400MHz, CDCl 3 )δ8.47–8.35(m,1H),7.48–7.27(m,7H),7.16(m,3H),7.01(dd,J=9.1,2.7Hz,1H),5.85(s,2H),3.59 (s,3H). 13 C NMR (100MHz, CDCl 3 )δ 158.9, 155.7, 147.9, 141.0, 139.9, 135.6, 129.4, 128.2, 125.5, 125.4, 124.4, 123.3, 121.9, 119.2, 117.6, 113.6, 109.6, 105.8, 102.9, 55.7, 4KBr ,1457,1446,1385,1198,975,777,746,734.HRMS(EI)...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 
![Indolo[3,2-c] coumarin compounds, derivatives thereof and synthesis method thereof](https://images-eureka.patsnap.com/patent_img/11bb7963-1f40-4bf0-8ed0-ee2c8ffcf7db/FDA0001638665530000011.png)
![Indolo[3,2-c] coumarin compounds, derivatives thereof and synthesis method thereof](https://images-eureka.patsnap.com/patent_img/11bb7963-1f40-4bf0-8ed0-ee2c8ffcf7db/FDA0001638665530000012.png)
![Indolo[3,2-c] coumarin compounds, derivatives thereof and synthesis method thereof](https://images-eureka.patsnap.com/patent_img/11bb7963-1f40-4bf0-8ed0-ee2c8ffcf7db/FDA0001638665530000021.png)